Chronic Low Back Pain Clinical Trial
Official title:
The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain: a Multi-centre Randomized Trial
NCT number | NCT02145728 |
Other study ID # | MGH-14-UL |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2014 |
Est. completion date | December 2018 |
Verified date | December 2018 |
Source | University of Limerick |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate whether individual cognitive functional therapy (CFT), when compared to group exercise classes is effective in reducing pain and disability in patients with non-specific chronic low back pain.
Status | Completed |
Enrollment | 208 |
Est. completion date | December 2018 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Aged between 18 and 75 - Chronic low back pain greater than 6 months duration - Score greater than 14% for disability on Oswestry Disability Index (ODI) - Independently mobile (with or without aids), to be capable of participating in a rehabilitation programme Exclusion Criteria: - Primary pain area is not the lumbar spine (from T12-buttocks) - Leg pain as the primary problem (nerve root compression or disc prolapse with true radicular pain/radiculopathy, lateral recess/central or spinal stenosis with primary leg pain) - <6 months post lumbar spine or lower limb or abdominal surgery - Pain relieving procedures such as injection based therapy (e.g epidurals) and day case procedures (e.g rhizotomy) in the last 3 months - Pregnancy - Rheumatologic/inflammatory disease (e.g. rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis, lupus, scheuermann's disease) - Progressive neurological disease (e.g. multiple sclerosis (MS), parkinson's disease (PD), motor neuron disease (MND) - Unstable cardiac conditions - Red flag disorders like malignancy/cancer, acute traumas like fracture (<6 months ago) or infection, spinal cord compression/cauda equina |
Country | Name | City | State |
---|---|---|---|
Ireland | Ballina Primary Care Centre | Mayo | Connacht |
Ireland | Claremorris Primary Care Centre | Mayo | Connacht |
Ireland | Mayo General Hospital | Mayo | Connacht |
Lead Sponsor | Collaborator |
---|---|
University of Limerick | Curtin University, Health Service Executive, Ireland, KU Leuven, Mayo General Hospital, Ireland |
Ireland,
O'Sullivan P. It's time for change with the management of non-specific chronic low back pain. Br J Sports Med. 2012 Mar;46(4):224-7. doi: 10.1136/bjsm.2010.081638. Epub 2011 Aug 4. — View Citation
Vibe Fersum K, O'Sullivan P, Skouen JS, Smith A, Kvåle A. Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: a randomized controlled trial. Eur J Pain. 2013 Jul;17(6):916-28. doi: 10.1002/j.1 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Oswestry Disability Index (ODI) | Used to assess change in disability levels over the course of the trial and follow-up | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Numerical rating scale (NRS) | Measures pain intensity | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Socio-economic Conditions Index | Measures socio-economic status | Baseline | |
Secondary | Back Pain Beliefs Questionnaire | Assess a person's beliefs about their back pain | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Physical activity subscale of the Fear-Avoidance Beliefs Questionnaire (FABQ) | Assesses a person's level of fear-avoidance beliefs regarding physical activities. | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | The catastrophising subscale of the Coping Strategies Questionnaire (CSQ) | Assesses level of pain catastrophizing. | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Pain Self- Efficacy Questionnaire (PSEQ) | Assesses level of pain self-efficacy | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Subjective Health Complaints Inventory (SHC) | Assess level of subjective health complaints | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Nordic Musculoskeletal Screening Questionnaire | Assesses areas of bodily pain | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Stress subscale of the Depression, Anxiety and Stress scale (DASS 21) | Assesses patient's stress levels. | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Patient Satisfaction Questionnaire | Assesses patient satisfaction | At 8-14 weeks | |
Secondary | Short-Form Orebro Musculoskeletal Screening Questionnaire (OMSQ) | Stratifies patients into low, medium or high risk of delayed pain recovery and chronicity. | Measured at baseline | |
Secondary | Medication usage | To assess changes in levels of medication used. | Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months | |
Secondary | Economic evaluation | Assesses direct and indirect costs of both treatment arms to see which is more cost-effective. | 6, 12 and 36 months | |
Secondary | Level of co-interventions | Assesses the number/type of healthcare services availed of throughout the intervention period. | Baseline, post-intervention (at 8-14 weeks), 6, 12 and 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |